| Technology Name | Briefcase | Lead Researcher |
|---|---|---|
Dr. Sharon Merims, Hadassah Medical Center
Background
Many of the anti-neoplastic tyrosine kinase inhibitors are associated with prominent and sometimes dose-limiting dermatologic complications. Of severe clinical implication are the specific ... More | Benny Ofra |